InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. Details TBD.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on October 6, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or other parties involved.
Why It Matters
This filing indicates InfuSystem Holdings, Inc. is making a public disclosure under Regulation FD, which requires companies to share material information broadly.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational impact indicated.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- October 6, 2025 (date) — Date of Report
- Regulation FD (regulation) — Type of Disclosure
FAQ
What specific information is being disclosed under Regulation FD?
The provided filing excerpt does not specify the content of the Regulation FD disclosure.
When was the earliest event reported in this 8-K filing?
The earliest event reported is October 6, 2025.
What is the principal executive office address for InfuSystem Holdings, Inc.?
The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the Commission File Number for InfuSystem Holdings, Inc.?
The Commission File Number is 001-35020.
What is the I.R.S. Employer Identification Number for InfuSystem Holdings, Inc.?
The I.R.S. Employer Identification Number is 20-3341405.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-10-06 17:23:03
Filing Documents
- infu-20251006.htm (8-K) — 27KB
- exhibit9912q25investorpr.htm (EX-99.1) — 28KB
- exhibit9912q25investorpr001.jpg (GRAPHIC) — 93KB
- exhibit9912q25investorpr002.jpg (GRAPHIC) — 200KB
- exhibit9912q25investorpr003.jpg (GRAPHIC) — 107KB
- exhibit9912q25investorpr004.jpg (GRAPHIC) — 111KB
- exhibit9912q25investorpr005.jpg (GRAPHIC) — 126KB
- exhibit9912q25investorpr006.jpg (GRAPHIC) — 94KB
- exhibit9912q25investorpr007.jpg (GRAPHIC) — 115KB
- exhibit9912q25investorpr008.jpg (GRAPHIC) — 94KB
- exhibit9912q25investorpr009.jpg (GRAPHIC) — 101KB
- exhibit9912q25investorpr010.jpg (GRAPHIC) — 99KB
- exhibit9912q25investorpr011.jpg (GRAPHIC) — 103KB
- exhibit9912q25investorpr012.jpg (GRAPHIC) — 127KB
- exhibit9912q25investorpr013.jpg (GRAPHIC) — 92KB
- exhibit9912q25investorpr014.jpg (GRAPHIC) — 106KB
- exhibit9912q25investorpr015.jpg (GRAPHIC) — 98KB
- exhibit9912q25investorpr016.jpg (GRAPHIC) — 92KB
- exhibit9912q25investorpr017.jpg (GRAPHIC) — 85KB
- exhibit9912q25investorpr018.jpg (GRAPHIC) — 108KB
- exhibit9912q25investorpr019.jpg (GRAPHIC) — 81KB
- exhibit9912q25investorpr020.jpg (GRAPHIC) — 116KB
- 0001628280-25-044357.txt ( ) — 3137KB
- infu-20251006.xsd (EX-101.SCH) — 2KB
- infu-20251006_lab.xml (EX-101.LAB) — 21KB
- infu-20251006_pre.xml (EX-101.PRE) — 12KB
- infu-20251006_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure InfuSystem Holdings, Inc. (the "Company") hereby furnishes the information set forth in the Investor Presentation dated October 6, 2025 , which is attached hereto as Exhibit 99.1. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the Investor Presentation attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 InfuSystem Holdings, Inc. Investor Presentation dated October 6, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: October 6, 2025